100%(3)100% нашли этот документ полезным (3 голоса)
506 просмотров14 страниц
1. The document discusses cellular aberrations and the cell cycle. It describes the four phases of the cell cycle - G1, S, G2, and M phase - and notes a fifth phase, G0, as a resting phase.
2. Oncology nursing is described as caring for cancer patients through the wide range of physical, emotional, social, and spiritual crises that arise. Nurses must support patients using standards of practice and the nursing process.
3. Cellular aberrations, or cancers, are characterized by abnormal cell growth and the potential to spread, or metastasize. The term cancer refers to diseases where cells grow and spread unrestrained.
1. The document discusses cellular aberrations and the cell cycle. It describes the four phases of the cell cycle - G1, S, G2, and M phase - and notes a fifth phase, G0, as a resting phase.
2. Oncology nursing is described as caring for cancer patients through the wide range of physical, emotional, social, and spiritual crises that arise. Nurses must support patients using standards of practice and the nursing process.
3. Cellular aberrations, or cancers, are characterized by abnormal cell growth and the potential to spread, or metastasize. The term cancer refers to diseases where cells grow and spread unrestrained.
Авторское право:
Attribution Non-Commercial (BY-NC)
Доступные форматы
Скачайте в формате PDF, TXT или читайте онлайн в Scribd
1. The document discusses cellular aberrations and the cell cycle. It describes the four phases of the cell cycle - G1, S, G2, and M phase - and notes a fifth phase, G0, as a resting phase.
2. Oncology nursing is described as caring for cancer patients through the wide range of physical, emotional, social, and spiritual crises that arise. Nurses must support patients using standards of practice and the nursing process.
3. Cellular aberrations, or cancers, are characterized by abnormal cell growth and the potential to spread, or metastasize. The term cancer refers to diseases where cells grow and spread unrestrained.
Авторское право:
Attribution Non-Commercial (BY-NC)
Доступные форматы
Скачайте в формате PDF, TXT или читайте онлайн в Scribd
Acute Biologic Crisis (ABC), Emergency and Disaster Nursing (NCM106) Cellular Aberration I
Cellular Aberration - Basic structural and functional unit of an organism
Cell Cycle - Is a coordinated sequence of events resulting in duplication of DNA and division into 2 daughter cell
4 Phases of the Cell Cycle 1. G1 / Gap Phase Lasts from hours to days / longer RNA and Protein synthesis occurs in preparation for DNA replication 2. S Phase / Synthesis Phase Lasts from 10 20 hours DNA replication in preparation for division 3. G2 / Gap 2 Ranges from 2 10 hours DNA synthesis while RNA and Protein synthesis continues 4. M Phase / Mitosis Phase Lasts from 30 60 minutes Cell division occurs After mitosis the daughter cells enter the G1 Phase and begin the reproductive cycle again 5. G0 / Resting Phase Is activity to reenter the cell cycle in response to various stimuli that signal for cell renewal
CELL CYCLE
Oncology Nursing - Field of specialty - Nurse must be equipped to support patient and family through a wide range of physical, emotional, social, cultural and spiritual crises - Provide realistic support to those receiving nursing care and use standards of practice and nursing process as basis of care
Cellular Aberration - A group of disorders characterized by abnormal cell growth and the ability to metastasize with potential in killing the host - The term cancer refers to the group of diseases in which cells grow and spread unrestrained throughout the body - Derived from the Latin word crab which means Cancer - Synonymous with neoplasm
LOOKY HERE 1. Introduction on Cellular Aberration 2. Multistage Theory of Oncogenesis 3. Tumor Invasion and Metastasis 4. Primary Prevention and Control 5. Secondary Prevention and Early Detection 6. Staging 7. Chemotherapy
jcmendiola_Achievers 2013 INCIDENCE and EPIDEMICS Male Female Most Common Cause of Death Most Common Cause of Death Prostate Cancer (33%) Lung Cancer (31%) Breast Cancer (32%) Lung Cancer (27%) Lung Cancer (13%) Prostate Cancer (10%) Lung Cancer (12%) Breast Cancer (15%) Colorectal Cancer (10%) Colorectal Cancer (10%) Colorectal Cancer (11%) Colorectal Cancer (10%) Bladder Cancer (7%) Pancreatic Cancer (5%) Endometrial Cancer (6%) Ovarian Cancer (6%) Cutaneous Melanoma (5%) Leukemia (4%) Non-Hodgkins Lymphoma (4%) Pancreatic Cancer (6%)
TOP 5 Cancer Incidences by Site and Sex Male Female 1. Prostate 1. Breast 2. Lungs 2. Lungs 3. Colon 3. Colon 4. Urinary Tract 4. Uterus 5. Leukemia 5. Leukemia and Lymphoma
Women Men - Breast Cancer followed by lung and colon and rectum - High incidence of cancer of the lung and bladder - Most common neoplasm aged 20 34; testicular Cancer
Etiologic Agent 1. Viruses and Bacteria Oncogenic viruses Prolonged / frequent viral infections may cause breakdown of the immune system / overwhelm the immune system 2. Chemical Carcinogens Act by causing cellular mutation / alterations in cell enzymes and protein E.g. Industrial compounds vinyl chloride, polycyclic aromatic hydrocarbons, fertilizers, weed killers, dyes and drugs 3. Physical Agents Radiation X-ray / radioactive isotopes and sunlight / UV Rays Physical Irritation/ trauma Pipe smoking, multiple deliveries, ragged tooth, irritation of the tongue, overuse of any organ / body part 4. Hormonal Agents Estrogen as replacement therapy incidence of vaginal and cervical adenocarcinoma Estrogen, diethylstilbestrol (DES) 5. Genetics and Familial Factors Oncogene When exposed to carcinogens Changes in the cell structure Becomes malignant
Predisposing Factors 1. Age Older individuals exposed to carcinogens longer develop immune system alterations 2. Sex Women = Breast, Uterus, Cervix Cancer Men = Prostate, Lung Cancer 3. Occupation E.g. Chemical factory worker, radiology department personnel 4. Hereditary Greater risk with positive family history
jcmendiola_Achievers 2013 Urban Versus Rural Incidence - Common among URBAN DWELLERS than RURAL RESIDENCES (Greater exposure to carcinogens) - Geographic Distribution o Cancer in stomach Japan o Breast Cancer US; due to environmental diet, ethnic customs and types of pollution
5. Psychological Stress Depression, grieving, anger, aggression, despair or life stresses decreases immune competence (Affects hypothalamus and pituitary gland) Immunodeficiency may spurt the growth and proliferation of Cancer cells
6. Precancerous Lesions o May undergo transfer into cancer lesion and tumor o E.g. Pigmented moles, burn scars, senile keratosis, leukoplakia, benign polyps, adenoma of the colon / stomach fibrocystic disease of the breast 7. Obesity Studies have linked obesity to breast and colorectal Cancer
Factors to Consider MR JUAN DELA CRUZ
Etiology - Carcinogens The process of transferring a normal cell into cancerous cell which consists of 3 Stages 1) Initiation (Carcinogen) 2) Promotion, repeated exposure to promote agents (Carcinogen) 3) Progression ( Malignancy behavior)
D Drugs E Educational Attainment L Living Conditions A Ask family History C Culture R Radiation Therapy U Ur Activity Z Zex M Marital Status R Race J Job U Ur Life Style A Age N Nutrition
jcmendiola_Achievers 2013 Multistage Theory of Oncogenesis 1. Cellular Transformation and Pre-agent Theory + Conceptualize that normal cells may be transformed into cancer cells due to exposure to etiologic agents 2. Failure of the Prime Resource Theory + Advocates that all individuals possess cancer cells, however the cancer cells are recognized by the immune system so the cancer cells undergo destruction + Failure of the immune response system leads to inability to destroy the cancer cells
TERMS 1. Cell Proliferation Is the process whereby cells divide and bear offspring, it normally is regulated so that the number of cells that are actively dividing is equal to the number of dying / being shed 2. Differentiation Is the process whereby proliferative cells are transformed into different and more specialized cell types, as they proliferate it determines what a cells looks like, and how it functions, how long it will live 3. Apoptosis It is the process of programmed death of unwanted cells
BENIGN GROWTH PATTERN 1. Hypertrophy In cell size resulting in an in organ size! 2. Hyperplasia A reversible in the number of cells in an organ or tissue in response to a specific growth stimulus 3. Metaplasia Conversion of one cell type to another cell type not usually found in the involved tissue 4. Dysplasia Characterized by abnormal changes in the size, shape, or organization of cells Reversible when stimulus is removed
jcmendiola_Achievers 2013 5. Anaplasia Disorganized irregular cells that have no structure and have loss of differentiation, the result is almost malignant
CLASSIFICATIONS OF TUMORS 1. Benign + Are tumors designated by attaching the suffix oma to the cells of organ + E.g. Fibroma, Chondroma,, Osteoma 2. Malignant + Tumors that are capable of spreading by invasion and metastasis + E.g. Fibrosarcoma, Chondrosarcoma
CATEGORIES OF MALIGNANT NEOPLASMS 1. Carcinogens Growth from epithelial cells, usually solid tumors 2. Sarcoma Arise from muscle, bone, fat and connective tissue, may be solid 3. Lymphoma Arise from lymphoid tissues 4. Leukemia and Myeloma Grows from blood forming organs
Tumor Invasion and Metastasis Invasion Occurs when cancer cells infiltrate adjacent tissues surrounding the neoplasm Metastasis Occurs when malignant cells travel through the blood / lymph and invade other tissues and organs to form a secondary tumor Types of Metastasis Extension and Invasion 1. Lymphatic Spread 2. Seeding of body cavities and surfaces 3. Hematogenous spread Spread of cancer cells from a primary tumor to distant sites Break away Only malignant cells has the capability Lymph, blood, serosal seeding
jcmendiola_Achievers 2013 Comparison of the Characteristics of Benign and Malignant Neoplasms Characteristics Benign Malignant Speed of Growth Slow growth Grows by expansion Aggressive growth; rapid cell division and growth Mode of Growth Localizes and encapsulation Establishes new site malignant lesion Cellular Characteristics Well-differentiated Invade surrounding tissues Metastasis It does not metastasize No tissue damage With poor cellular differentation Prognosis Very good prognosis Does not cause death, unless localization affects vital functions
Malignant Cells Mitosis o Mitosis Multiple daughter cells that may / may not resemble the parent, multiply mitotic spindles 1. Larger, grows more rapidly than normal cells 2. Cells not as cohesive, irregular pattern of expansion 3. Larger, more prominent nucleus 4. Lack characteristic pattern of organization of host cells 5. Anaplastic = Lack of differentiated cell characteristics specific function
Malignant Cells Growth 1. Invade adjacent tissues 2. Proliferation in response to abnormal stimulus 3. Grow in adverse condition such as lack of nutrients 4. Do not exhibit contact-inhibition 5. Cell birth exceeds cell death 6. Loss of cell control as a result of cell membrane changes 7. Growth rate, erratic 8. Able to break off cells that migrate through blood stream / lympati** seed to distant sites and grow in other sites
Malignant Cells Function 1. Senseless, no useful purpose 2. Do not contribute to the well-being of the host, parasitic 3. If the cells function at all, they do not function normally may cause damage
Malignant Cells 1. Develop antigens completely different from a normal cell 2. Chromosomal aberrations occur as a cell matures 3. Has a more prominent and simplified metabolic enzyme pattern 4. Invasive and spreads 5. Grow in presence of necrosis and inflammatory cells such as lymphocytes and macrophages 6. Exhibit periods of latency that vary from tumor to tumor 7. Have own blood supply and suppository stoma (Angiogenesis factory 2 cm in diameter)
jcmendiola_Achievers 2013 Primary Prevention and Control WARNING SIGNS OF CANCER (CAUUUTIONALF) C Change in bowel / bladder habits A A sore that does not heal U Unusual bleeding / discharge U Unexplained sudden weight loss U Unexplained anemia T Thickening / lump in the breast or elsewhere I Indigestion or difficulty in swallowing O Obvious change in wart / mole B Nagging cough / hoarseness A Anemia L Loss of weight F Fever of unknown origin
Screening 1. Familial and environmental history 2. Physical Examination 3. Evaluation of laboratory findings and test findings 4. Screening methods Brest Monthly BSE = all women ages 20 and above 1 week after menses Mammography every year from age 40 years old Colon and Rectum Fecal occult blood test every year beginning at age 50 Proctosigmoidoscopy every 3- 5 years after 50 years old following 2 negative annual exams Uterus Yearly pelvic examination and PAP Smear test for sexually active girls and any woman over 18 or less often for 3 consecutive negative results An endometrial sample at menopause for high risk women Prostate Digital Rectal Exam (DRE) yearly beginning at age 50 Prostate-Specific Antigen (PSA) test yearly beginning at age 50
Secondary Prevention and Early Detection NON INVASIVE DIAGNOSTIC PROCEDURES ^ Diagnostic Imaging Methods Important in the diagnosis and staging of cancer Used to guide the surgeon to the appropriate area for biopsy Use of this modality is guided by physical examination Clinical instruction through collaboration with the radiology specialist ^ X-RAY Sites speaks View the dynamic function of an organ ^ Mammography Used to screen for malignancies of the breast Should be conducted with clinical findings ^ CT Scan Obtain images from various angles through the body such as lungs, soft tissue, blood vessels Preferred method for diagnosis, liver, kidney and pancreatic cancer 10 Steps for Cancer Prevention and Protective Factors 1. Increase consumption of fresh vegetables 2. Increase fiber intake 3. Increase Vitamin A 4. Increase Vitamin C 5. Practice weight control 6. Decrease dietary fat and 7. Decrease salt 8. Stop cigarette smoking 9. Decrease alcohol intake / substance abuse 10. Void overexposure to sun
jcmendiola_Achievers 2013 ^ MRI Preferred imaging technique for soft tissue structures, hematologic imaging, vascular imaging and avascular necrosis Not exposed to radiation
INVASIVE DIAGNOSTIC PROCEDURE * Histologic / Cytologic Examination o For malignant tissues to be identified by name, grade and stage o Morphologic feature of the cells are examined 3 Basic Methods of Specimen Collection 1. Exfoliation from an epithelial surface (pap smear) or bronchial washing 2. Aspiration of fluid from body cavities or blood 3. Needle suction aspiration of solid tumor * Direct Visualization 1. Sigmoidoscopy (Viewing the sigmoid colon by use of fiberoptic flexible sigmoidoscopes 2. Cystoscopy (Viewing the urethra and bladder) 3. Endoscopy (Viewing of the upper GIT) 4. Bronchoscopy (Inspection of the tracheobronchial tree LABORATORY STUDIES Tumor Markers Biochemical substances synthesized and released by tumor cells May be protein products exerted by cancer cells, released in response to the presence of cancer cells or other conditions Used to aid in the diagnosis of cancer to determine recurrence or identify regression of a known malignancy TUMOR MARKER DESCRIPTION 1. Oncofetal Antigen Present in fetal tissue normally suppressed after birth 2. Hormones Present in considerable amount High levels in hormone-secreting malignancies 3. Isoenzymes Elevated levels can promote hyperplasia of the tissue (Prostate acid phosphatase) 4. Tissue-Specific Protein Narrows down the type of malignancy that can be increased in hyperplastic disorders 5. Prostate-Specific Antigen Useful in evaluating response to treatment, recurrent surgery / radiation therapy Elevated in prostate cancer, can be elevated in BPH in older men, should be accompanied with DRE 6. S-100 Found in melanoma cells Elevated means METASTATIC MELANOMA 7. Thyroglobulin Protein made by the thyroid gland Removal of the entire gland with or without radiation therapy Rise in thyroglobulin levels indicate cancer recurrence 8. Estrogen and Progesterone Receptors Once diagnosed, breast cancer tissue become tested for the presence of E and P receptors Provides an indication of the aggressiveness of the cancer and how likely the cancer will respond to specific types of endocrine therapy 9. Ca 15 3 and Ca 27 29 Specific for BREAST CANCER Found in the blood of an affected patient Ca 27 29 test is MORE sensitive than Ca 15 3 10. Carcinoembryonic Antigen (CEA) and Ca 19 9 Elevated in ADVANCED COLORECTAL CANCER CEA level before surgery POORER PROGNOSIS 11. Human Chorionic Gonadotropin (HCG) and Alpha-fetoprotein (AFP) With germ cell ovarian tumors in men with non-seminomatous TESTICULAR CANCER = Elevated HCG and AFP Proportionately to the size of tumors AFP levels may also be increased in CHRONIC HEPATITIS
jcmendiola_Achievers 2013 12. Beta-2-Microglobulin (B2M) Elevated in periods with multiple myeloma with chronic lymphocytic leukemia, kidney disease 13. HER-2 / NEU Elevated in one-thirds of persons diagnosed with breast cancer
Laboratory Tests - Complete Blood Count (CBC) - Blood Chemistry ) Serum electrolytes ) ALT Alanine Aminotransferase ) AST Aspartate Aminotransferase ) LDH For liver metastases ) CEA For colon cancer
STAGING Done during the pre-treatment phase After surgical resection Recurrence after disease free interval
STAGING TUMOR Tumor TNM Staging System T0 No end of primary tumor Tis Carcinoma in situ T1, T2, T3, T4 Progressive increase in tumor size and involvement Tx Tumor cannot be assessed
STAGES Stage I The tumor is small, local, detected early Stage II The tumor is somewhat larger and has started to spread to nearby lymph nodes Stage III The tumor has spread to nearby lymph nodes Stage IV Cancer has spread to other parts of the body and is generally in an advanced stage
STAGING NODE N0 Regional lymph nodes N1, N2, N3 degree of demonstrable abnormality of regional lymph nodes Nx Regional lymph nodes cannot be assessed clinically
STAGING METASTASIS M0 No evidence of distant metastasis M1, M2, M3 Ascending degree of distant metastasis, including metastasis to different lymph nodes
GRADING Gx Grade cannot be assessed G1 Well differentiated G2 Moderately well-differentiated G3 and G4 Poorly to very poorly differentiated Poorer differentiation poorer prognosis
Classification, Grading and Stages TNM Classification T Extent of primary tumor Tx Cannot be adequately assessed T0 No evidence of primary tumor Tis Tumor in situ 0 localized; no spread T1 4 prognosis, increase in size 1.5 cm < 2: 6-9 cm 3:10-15 cm 4:15 cm >
jcmendiola_Achievers 2013 STAGES 0 Benign state I Spread to nearby tissue II 2 5 cm sometimes involve lymph III Greater than 5 cm spread advanced spread to connective tissue IV Metastasis
Grading of Tumor Grade I Well differentiated Grade II Moderately well differentiated Grade III Poorly differentiated Grade IV Undifferentiated
CHEMOTHERAPY E A systematic mode of treatment that uses cytotoxins and chemicals to effectively CURE (Leukemia, Lymphomas, some solid tumors) Tumor size Adjunct to surgery / radiation Prevent / treat suspected metastasis E Most effective when the tumor is small and cell replication is rapid E Individualized to the patient and is often prescribed according to the patients calculated body surface area and type of cancer E Example: Acute Lymphocytic Leukemia (ALL) Uses DVPA Daunorubicin Given days 1 3 Vincristine Given days 1, 8, 15 and 22 Prednisone Given days 11 28 Asparaginase Given days 17 28 Given in cycles with rest periods (especially if with toxic effects) until disease goes to remission
Chemotherapy Cell Cycle - Used to disrupt the cell cycle in various phases in specific protocols that are given over varying periods of time
Cell Kill Hypothesis 1. Several doses of chemotherapy are necessary 2. Each exposure kills: 20% - 99% depending on dosage 3. Repeated exposure targets even those in G0 and leads to regression 4. 100% eradication of tumor cells IMPOSSIBLE 5. But the goal is: To reduce the amount that can be destroyed by the immune system
Factors Crucial to the Rate of Normal / Malignant Tissues 1. Cell Cycle Timing: Amount of time required for cells to remove from one mitosis to the next 2. Growth Fraction: Ratio of dividing cells to resting cells, fraction of cycling cells in the entire cell population 3. Rate of Cell Loss: Fracture of cell die or leaves
Route of Chemotherapy 1. Oral Hodgkins Lymphoma, Leukemia (Maintenance phase), Lung Cancer 2. Intravenous Leukemia, 3. Intra-arterial Hepatic tumors, head and neck cancer 4. Intracavity Ovarian cancer New RESEARCH! Use of chemotherapy based on CIRCARDIAN RHYTHMS E.g. Colon Cancer
OBJECTIVES: - To destroy all malignant tumor cells without excessive destruction of normal cells - To control growth if cure is no longer possible - Used as adjunct therapy
CONTRAINDICATIONS * Infection: Anti-tumor drugs are immunosuppressive * Recent surgery: Drugs may retard healing process * Impaired renal / Hepatic Function: Drugs are nephrotoxic and hepatotoxic * Recent Radiation Therapy: Immunosuppressive * Pregnancy: Drugs may cause congenital defects * Bone Marrow Depression: Drugs may aggravate the condition, WBC must be within normal levels
Safe Handling of Chemotherapeutic Agents - Wear mask, gloves and back-closing gown - Skin contact with drugs must be washed immediately with soap and water. Eye must be flushed immediately with copious amount of water - Sterile / Alcohol Wet cotton pledgets should be used, wrapped around the neck of the ampule / vial when breaking and withdrawing the drug - Expel air bubbles or wet cotton - Vent vials to reduce internal pressure after mixing - Wipe external surface of syringe and IV bottles - Avoid self-inoculation by needle stab - Clearly label the hanging IV bottle with antineoplastic chemotherapy - Contaminated needles and syringes must be disposed in a clearly marked special container leak-proof or puncture proof - Dispose half-empty ampules, vials, IV bottles by putting them into plastic bags sealed and then into another plastic bag or box, clearly marked before placing for removal. Label as Hazardous Wastes - Handwashing should be done before and after removal of gloves - Trained personnel only should be involved in use of drugs
Effects of Chemotherapeutic Drugs Tissues normally affected are: 1. Mucous Membranes Mouth, tongue, esophagus, stomach, intestine and rectum Results in anorexia, loss of taste, aversion to food, Erythema, painful ulceration of GIT, NV, diarrhea 2. Hair Cells Alopecia 3. Bone Marrow Depression Affects: Granulocytes, lymphocytes, thrombocytes, erythrocytes Impaired ability to respond to infection, blood clot and severe anemia 4. Organ Heart, lungs, bladder, kidney Due to specific agents E.g. Cardiac toxicity (Doxorubicin) Pneumocystis (Bleomycin)
Effects of CHEMO DRUGS 1. Combined medication therapy is used to enhance tumor cell kill 2. Synergistic actions of drugs will prevent the development of drug resistance 3. Combats resistance of cells to chemotherapeutic agents
jcmendiola_Achievers 2013 Classification of Chemotherapeutic Drugs Related to the cell cycle 1. Cycle Specific Agents They are specific to certain phases of the cell cycle Destroy cells that are actively reproducing Most affects there in the S Phase of interfering with DNA and RNA synthesis M Phase (Vinca / Plant Alkaloids: Halt spindle function) 2. Cycle Non-Specific Agents Act independently of the cell cycle place Usually have prolonged effects or cells leading to cell death and damage
Classifications of Drugs 1. Alkylating Agents Contains alkyl groups which binds to DNA and prevents replication and mitosis Cell Cycle non-Specific Effective against many types of cancer, including acute and chronic leukemia, solid tumors Common Side Effects - Bone marrow suppression - N/V - Alopecia - Sterility - Cystic cyclophosphamide - Stomatitis - Renal Toxicity (Cisplastin) E.g. Bisulfiram (Bisulflex) Cyclophosphamide (Cytoxan) Chlorambucil (Leukeran) Cisplastin (Planitol-AQ) Nursing Implications: Maintain good hydration Administer anti-emetics prior to chemotherapy Monitor WBC, Uric Acid Assess for possible infection Discuss concerns for hair loss 2. Nitrosoureas Similar to the alkylating agent ONLY CHEMODRUG THAT CAN CROSS THE BLOOD BRAIN BARRIER (BBB) [Important for Central Nervous System diseases] Side Effects: Delayed cumulative myelosuppression (In 3 5 weeks) especially thrombocytopenia; N/V Nursing Implications: Maintain good hydration Administer anti-emetics prior to chemotherapy Monitor WBC, Uric Acid Assess for possible infection Discuss concerns for hair loss 3. Anti Metabolites Interferes with the biosynthesis of metabolism or nucleic acid needed for RNA and DNA synthesis Cell specific (Best in S Phase) Used to treat acute leukemia, breast cancer, head and neck cancer, lung cancer, and osteosarcoma Side Effects: Bone Marrow suppression (Anemia, leukopenia)
jcmendiola_Achievers 2013 Stomatitis N/V Alopecia Hepatitis and renal dysfunction E.g. Methotrexate - Lethal in high doses, must give antidote (Leucovorin) within 24 36 hours after initiation of therapy - 5-Flurouracil (5-FU) - Cytarabine (Depocyt, Tarabine) - 5-Azacytidine Side Effects N/V Diarrhea Bone Marrow suppression: Reaches NADIR in 1 2 weeks; with leukopenia being most severe Renal toxicity (Methotrexate) Hepatotoxicity Nursing Implications Monitor CBC, WBC, Uric acid Assess oral mucus membranes Assess for infection, bleeding Provide oral care Administer anti-emetics PRN Discuss concern for hair loss Evaluate hydration and nutritional status 4. Antitumor Antibiotics Inhibit RNA synthesis and bind DNA causing fragmentation; interfere with DNA repair These drugs bind to almost everything they contact and kill cells Main toxic effect is cardiac muscle toxicity (Limits the amount and duration of treatment) Side Effects are the same with other anti-Cancer drugs E.g. Doxorubicin (Adriamycin) Bleomycin (Blenoxane) Dactinomycin (Cosmegen) Nursing Implications Monitor ECG, CBC Assess for bleeding Assess for hydration and nutritional status Check for fever 36 hours after administration Administer anti-emetic PRN 5. Plant Alkaloids Two main Groups (From natural products) 1. Vinca Alkaloids Mitosis phase, inhibit mitotic tubular formation (spindle); inhibit DNA and protein synthesis 2. Etoposide (VP-16) or Mitotic Inhibitors All phases; causes breaks in DNA and metaphase arrest E.g. 1. Vincristine (Oncovin) Vinblastin (Velban) 2. Etoposide (Toposar) Teniposide (Venom) Side Effect: Hypotension (Too rapid IV administration), muscle weakness, areflexia, constipation, N/V, alopecia Nursing Implications: NADIR Is the lowest level of a red blood cell count while a patient is undergoing chemotherapy
jcmendiola_Achievers 2013 Assess neuromuscular functions Monitor CBC, GI function Manage constipation Hydration Discuss concerns for hair loss 6. Hormonal Agents Alter the deviate / environment to depress / prevent cell proliferation Corticosteroids (e.g. Prednisone: Mostly used in CA therapy; G1 Phase) E.g. Androgen, estrogen, anti-androgens, anti-estrogens Side Effects N/V Hyperglycemia Hypertension Weight gain; gynecomastia Mood changes Cessation of menstruation Acne, alopecia
Nursing Interventions for Chemical Side Effects GI System = N/V, diarrhea, constipation Administer anti-emetics to relieve N/V Replace fluids and electrolyte losses, low fiber diet to relieve diarrhea fluid intake and fibers in diet to prevent / relieve constipation Integumentary System Pruritus; urticaria and systemic signs - Provide good skin care Stomatitis - Provide good oral care, avoid HOT and SPICY food Alopecia - Reassure that it is temporary, wear wigs / hats Skin Pigmentation - Inform that it is temporary Nail changes (Grow normally after chemotherapy) Hematopoietic System Anemia - Frequent rest periods, eat foods high in Iron! Neutropenia - Protect from infection - Avoid people with infection Thrombocytopenia - Protect from trauma - Avoid ASA Genito-Urinary System Hemorrhagic Cystitis - Provide 2 3 L of fluids per day Urine color changes - Reassure that it is harmless